相关实验视频

Updated: Feb 17, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

19.0K

在P-Tau217,Tau聚合和认知衰退中的性别差异

Gillian T Coughlan1,2, Valentin Ourry3, Diana Townsend1

  • 1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

JAMA neurology
|February 16, 2026
PubMed
概括

妇女显示积增加和认知下降与更高的粉样β水平,特别是当可溶性化217 (p-tau217) 存在. 这表明阿尔茨海默病的性别特异性进展受到早期生物标志物的影响.

更多相关视频

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

19.8K
Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

28.2K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K